FDA Adverse Event Injury Summary report: N

EQUINOXE REVERSE 38MM HUMERAL LINER +0

MDR report key: 14880992 · Received June 30, 2022

Report

Report Number
1038671-2022-00750
Event Type
Injury
Date Received
June 30, 2022
Date of Event
June 20, 2022
Report Date
August 30, 2022
Manufacturer
EXACTECH, INC.
Product Code
KWT
UDI-DI
10885862086655
PMA / PMN Number
K063569
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CUSTOMER SENT EXPLANTED DEVICE TO BIO ENGINEERING FOR ANALYSIS. CONCOMITANTS: 300-01-13 EQUINOXE, HUMERAL STEM PRIMARY, PRESS FIT 13MM- 7113985; 320-20-00 EQ REVERSE TORQUE DEFINING SCREW KIT- 7151324; 320-10-00 EQUINOXE REVERSE TRAY ADAPTER PLATE TRAY +0- 7012819; 320-15-05 EQ REV LOCKING SCREW- 7236899; 320-01-38 EQUINOXE REVERSE 38MM GLENOSPHERE- 6818376; 320-15-07 SUP/POST AUG PLATE, L RS GLENOID BASEPLATE- 5899654.

Additional Manufacturer Narrative · 0

H2: BASED ON REVIEW OF ALL AVAILABLE INFORMATION, THERE IS NO EVIDENCE TO SUGGEST THAT THE REPORTED EVENT IS RELATED TO ANY DESIGN OR MANUFACTURING ISSUES. THE CAUSE OF SURGICAL REVISION FOR IMPINGEMENT CANNOT BE CONCLUSIVELY DETERMINED; HOWEVER, IT IS MOST LIKELY RELATED TO THE PATIENT¿S UNDERLYING CONDITION.

Description of Event or Problem · 0

IT WAS REPORTED A (B)(6) MALE PATIENT, LEFT SHOULDER INITIALLY IMPLANTED ON (B)(6) 2022, HAD GREATER TUBEROSITY IMPINGEMENT. ON (B)(6) 2022, THE SURGEON PERFORMED A SERIES OF RELEASES AND SWAPPED THE POLY LINER. SURGEON REPLACED THE POLY LINER FOR A CONSTRAINED OPTION AND INCREASED THE HEIGHT. THE PATIENT WAS LAST KNOWN TO BE IN STABLE CONDITION FOLLOWING THE EVENT. THE DEVICE IS NOT AVAILABLE FOR RETURN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1401976 EQUINOXE REVERSE 38MM HUMERAL LINER +0 PROSTHESIS, SHOULDER, NON-CONSTRAINED, METAL/POLYMER KWT EXACTECH, INC. EQUINOXE REVERSE 38MM HUMERAL LINER +0 UNK 10885862086655

Patients

Seq Age Sex Outcome Treatment
1 80 YR Male Required Intervention SEE H10.